Arnold Lockshin
- Oncology top 10%
-
- Cancer, Hypoxia, and Metabolism 4
-
- Biochemical and Molecular Research 7
- Cancer therapeutics and mechanisms 4
- Enzyme function and inhibition 2
-
- Folate and B Vitamins Research 4
-
- Radiopharmaceutical Chemistry and Applications 4
- Monoclonal and Polyclonal Antibodies Research 3
-
- Enzyme Structure and Function 3
- Co-authors
- Peter V. DanenbergP. V. DanenbergR. H. BurrisR G MoranJohn S. StehlinGiovanella BcStehlin JsBeppino C. Giovanella
- Journals
- Cancer Letters (3 papers)Journal of Biological Chemistry (2 papers)Proceedings of the National Academy of Sciences (2 papers)
- Partner nations
- United States
In The Last Decade
Arnold Lockshin
22 papers receiving 505 citations
Peers
Comparison fields: 5 of 84
- Oncology 241
- Cancer Research 97
- Molecular Biology 327
- Rheumatology 54
- Renewable Energy, Sustainability and the Environment 43
Countries citing papers authored by Arnold Lockshin
This map shows the geographic impact of Arnold Lockshin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnold Lockshin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnold Lockshin more than expected).
Fields of papers citing papers by Arnold Lockshin
This network shows the impact of papers produced by Arnold Lockshin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnold Lockshin. The network helps show where Arnold Lockshin may publish in the future.
Co-authorship network
The 14 scholars most cited alongside Arnold Lockshin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1987 | 5 | |
| 2 | 1987 | 4 | |
| 3 | 1986 | 4 | |
| 4 | 1986 | 11 | |
| 5 | Selective cytotoxicity of 5-hydroxyuridine for human colon adenocarcinoma cells. | 1985 | 2 |
| 6 | Exceptional lethality for nude mice of cells derived from a primary human melanoma. | 1985 | 82 |
| 7 | Antitumor activity and minimal toxicity of concentrated thymidine infused in nude mice. | 1985 | 4 |
| 8 | 1985 | 1 | |
| 9 | 1984 | 6 | |
| 10 | 1984 | 5 | |
| 11 | 1984 | 12 | |
| 12 | Cytotoxic and biochemical effects of thymidine and 3-deazauridine on human tumor cells. | 1984 | 10 |
| 13 | 1982 | 25 | |
| 14 | 1982 | 11 | |
| 15 | 1981 | 121 | |
| 16 | 1981 | 53 | |
| 17 | 1980 | 29 | |
| 18 | 1979 | 31 | |
| 19 | 1979 | 53 | |
| 20 | 1971 | 23 |
About Arnold Lockshin
Arnold Lockshin is a scholar working on Cancer Research, Rheumatology, Radiology, Nuclear Medicine and Imaging, Molecular Biology and Molecular Medicine, having authored 22 papers that have together received 555 indexed citations. Recurring topics across this work include Biochemical and Molecular Research (7 papers), Radiopharmaceutical Chemistry and Applications (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), Cancer therapeutics and mechanisms (4 papers), Folate and B Vitamins Research (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Enzyme Structure and Function (3 papers) and Enzyme function and inhibition (2 papers). The work is most often cited by research in Oncology (241 citations), Cancer Research (97 citations), Molecular Biology (327 citations), Rheumatology (54 citations) and Renewable Energy, Sustainability and the Environment (43 citations). Arnold Lockshin has collaborated with scholars based in United States. Frequent co-authors include Peter V. Danenberg, P. V. Danenberg, R. H. Burris, R G Moran, John S. Stehlin, Giovanella Bc, Stehlin Js, Beppino C. Giovanella, Lawrence Bogorad and Rodney H. Falk. Their work appears in journals such as Cancer Letters, Journal of Biological Chemistry, Proceedings of the National Academy of Sciences, JNCI Journal of the National Cancer Institute and Pathobiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.